Oyster Point Pharma, Inc.
OYSTDelisted Jan 3, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001720725
Oyster Point Pharma, Inc. was delisted on Jan 3, 2023; its insiders filed their last Form 4 on Jan 5, 2023; 53 institutions reported holding it in 13F filings for Q4 2022, worth $189.4M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Oyster Point Pharma, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
OYST is no longer listed, so this page shows Q4 2022. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 53
- −5 vs. Q3 2022
- Shares held
- 17.0M
- −3.06M (−15.3%) vs. Q3 2022
- Total value
- $189.4M
- +$76.9M (+68.4%) vs. Q3 2022
- New holders
- 18
- 12 more added
- Sold out
- 23
- 13 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OYST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $11 |
| Q1 2026 | 1 | $11 |
| Q4 2025 | 1 | $11 |
| Q3 2025 | 1 | $11 |
| Q2 2025 | 1 | $11 |
| Q1 2025 | 1 | $11 |
| Q4 2024 | 1 | $11 |
| Q3 2024 | 1 | $11 |
| Q2 2024 | 1 | $11 |
| Q1 2024 | 1 | $11 |
| Q4 2023 | 1 | $11 |
| Q3 2023 | 1 | $11 |
| Q2 2023 | 1 | $11 |
| Q1 2023 | 1 | $11 |
| Q4 2022 | 53 | $189.4M |
| Q3 2022 | 60 | $112.6M |
| Q2 2022 | 61 | $87.6M |
| Q1 2022 | 72 | $246.2M |
| Q4 2021 | 80 | $378.8M |
| Q3 2021 | 69 | $210.8M |
| Q2 2021 | 58 | $318.3M |
| Q1 2021 | 61 | $335.9M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Oyster Point Pharma, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Belpointe Asset Management LLC | 10 | $112 | 0.00% | +10 | New |
| Wells Fargo & Company | 115 | $1.28K | 0.00% | +3+2.7% | Added |
| IFP Advisors, Inc | 106 | $2.00K | 0.00% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 200 | $2.23K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 342 | $3.82K | 0.00% | +49+16.7% | Added |
| Simplex Trading, LLC | 500 | $5.00K | 0.00% | −4,733−90.4% | Reduced |
| Huntington National Bank | 896 | $10.0K | 0.00% | +83+10.2% | Added |
| Group One Trading, L.P. | 1,035 | $11.6K | 0.00% | −334−24.4% | Reduced |
| Freedom Wealth Alliance, LLC | 1,921 | $21.5K | 0.03% | +1,921 | New |
| BlackRock Inc. | 2,085 | $23.3K | 0.00% | −502,288−99.6% | Reduced |
| Advisor Group Holdings, Inc. | 2,250 | $25.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,997 | $34.0K | 0.00% | −82−2.7% | Reduced |
| Morgan Stanley | 7,986 | $89.2K | 0.00% | −136,542−94.5% | Reduced |
| Tower Research Capital LLC (TRC) | 8,861 | $99.0K | 0.00% | −32,050−78.3% | Reduced |
| Bank of America Corp | 11,057 | $123.5K | 0.00% | −2,394−17.8% | Reduced |
| Squarepoint Ops LLC | 11,375 | $127.1K | 0.00% | +11,375 | New |
| Crystalline Management Inc. | 11,421 | $127.6K | 0.06% | +11,421 | New |
| Coastal Bridge Advisors, LLC | 11,970 | $133.7K | 0.04% | 00.0% | Unchanged |
| Guggenheim Capital LLC | 12,816 | $143.2K | 0.00% | +12,816 | New |
| Vanguard Group Inc | 13,500 | $150.8K | 0.00% | −413,595−96.8% | Reduced |
| Geode Capital Management, LLC | 14,178 | $158.0K | 0.00% | −140,993−90.9% | Reduced |
| UBS Group AG | 15,787 | $176.3K | 0.00% | +13,123+492.6% | Added |
| Equitec Proprietary Markets, LLC | 17,266 | $192.9K | 0.11% | +17,266 | New |
| Goldman Sachs Group Inc | 18,261 | $204.0K | 0.00% | −77,425−80.9% | Reduced |
| Citigroup Inc | 18,878 | $210.9K | 0.00% | +18,564+5,912.1% | Added |
| Endurant Capital Management LP | 19,927 | $222.6K | 0.09% | +19,927 | New |
| HRT Financial LP | 24,900 | $278.0K | 0.00% | −17,017−40.6% | Reduced |
| JPMorgan Chase & Co | 25,532 | $285.0K | 0.00% | +23,817+1,388.7% | Added |
| Citadel Advisors LLC | 29,511 | $329.6K | 0.00% | −266,547−90.0% | Reduced |
| Wildcat Capital Management, LLC | 36,847 | $411.6K | 0.16% | 00.0% | Unchanged |
| Northern Trust Corp | 39,501 | $441.2K | 0.00% | +4,444+12.7% | Added |
| Bridgeway Capital Management, LLC | 40,000 | $446.8K | 0.01% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 44,115 | $492.8K | 0.03% | +44,115 | New |
| Bluefin Capital Management, LLC | 45,000 | $502.6K | 0.09% | +45,000 | New |
| Creative Planning | 107,662 | $1.20M | 0.00% | +1,000+0.9% | Added |
| Susquehanna International Group, LLP | 108,443 | $1.21M | 0.00% | +86,256+388.8% | Added |
| Gamco Investors, Inc. Et Al | 158,815 | $1.77M | 0.02% | +158,815 | New |
| Deltec Asset Management LLC | 162,042 | $1.81M | 0.52% | +162,042 | New |
| Gabelli & Co Investment Advisers, Inc. | 170,250 | $1.90M | 0.41% | +170,250 | New |
| Yakira Capital Management, Inc. | 174,763 | $1.95M | 0.40% | +174,763 | New |
| Millennium Management LLC | 206,254 | $2.30M | 0.00% | +99,703+93.6% | Added |
| Laurion Capital Management LP | 210,200 | $2.35M | 0.07% | 00.0% | Unchanged |
| Chicago Capital Management, LLC | 212,234 | $2.37M | 2.15% | +212,234 | New |
| Jane Street Group, LLC | 221,476 | $2.47M | 0.00% | +202,609+1,073.9% | Added |
| Man Group plc | 319,524 | $3.57M | 0.01% | +319,524 | New |
| MMCAP International Inc. SPC | 515,491 | $5.76M | 0.58% | +515,491 | New |
| GW&K Investment Management, LLC | 554,288 | $6.19M | 0.06% | −10,568−1.9% | Reduced |
| Gabelli Funds LLC | 651,051 | $7.27M | 0.06% | +651,051 | New |
| Westchester Capital Management, LLC | 655,044 | $7.32M | 0.21% | +655,044 | New |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $11.6M | 0.39% | 00.0% | Unchanged |
| RTW Investments, LP | 2,304,977 | $25.7M | 0.53% | +260,665+12.8% | Added |
| Invus Financial Advisors, LLC | 2,768,586 | $30.9M | 16.46% | 00.0% | Unchanged |
| NEA Management Company, LLC | 5,925,287 | $66.2M | 3.72% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,805,387−100.0% | Sold out |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −1,648,316−100.0% | Sold out |
| Telemark Asset Management, LLC | 0 | $0 | 0.00% | −777,026−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −509,794−100.0% | Sold out |
| KPCB XIV Associates, LLC | 0 | $0 | 0.00% | −367,987−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −77,427−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −48,934−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −20,182−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −14,172−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −14,248−100.0% | Sold out |
| HarbourVest Partners LLC | 0 | $0 | 0.00% | −12,560−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −12,100−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −10,834−100.0% | Sold out |
| Cherry Creek Investment Advisors, Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −7,000−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −2,761−100.0% | Sold out |
| GPS Wealth Strategies Group, LLC | 0 | $0 | 0.00% | −2,052−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −1,697−100.0% | Sold out |
| Gibson Wealth Advisors LLC | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −251−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| ACG Wealth | – | – | – | – | Not filed |
| ACT Capital Management, LLC | – | – | – | – | Not filed |